English
Copper Transporting ATPase 1 Antibody, Clone L60/4: APC
Mouse Anti-Human Copper Transporting ATPase 1 Monoclonal IgG2b
Artikelnummer
STRSMC-398D-APC
Verpackungseinheit
100 µg
Hersteller
Stressmarq Biosciences
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Target: ATP7A
Conjugate: APC
Product Type: Monoclonal
Clone Number: L60/4 (Formerly sold as S60-4)
Immunogen: Synthetic peptide amino acids 42-61 (cytoplasmic C-terminus) of human Copper- transporting ATPase1
Swiss-Prot: Q04656
Purification: Protein G Purified
Storage Buffer: PBS pH7.4, 50% glycerol, 0.09% sodium azide *Storage buffer may change when conjugated
Concentration: 1 mg/ml
Specificity: Detects ~180kDa in rat brain membrane preparations.
Cellular Localization: Endoplasmic Reticulum,Cytoplasm,Golgi Apparatus,Trans-Golgi Network Membrane,Cell Membrane
Scientific Background: The copper efflux transporters ATP7A and ATP7B sequester intracellular copper into the vesicular secretory pathway for export from the cell. ATP7A (also known as Copper-transporting ATPase 1) functions as a transmembrane copper-trans locating P-type ATPase and plays a vital role in systemic copper absorption in the gut and copper reabsorption in the kidney. Polarized epithelial cells such as Madin-Darby canine kidney cells are a physiologically relevant model for systemic copper absorption and reabsorption in vivo. Although ATP7A is not detectable in most normal tissues, it is expressed in a considerable fraction of many common tumor types. Increased expression of ATP7A renders cells resistant to cisplatin and carboplatin. Mutations in the ATP7A gene result in Menkes disease, which is fatal in early childhood. Mutations in the ATP7B gene lead to the autosomal recessive disorder, Wilson disease, characterized by neurological symptoms and hepatic damage.
References: 1. Samimi G., et al. (2003) Clin. Cancer Res. 9: 5853-9.2. Samimi G., et al. (2004) Mol Pharmacol. 66: 25-32.3. Greenough M., et al. (2004) Am. J. Physiol. Cell Physiol. 287: C1463-71.4. Song, I.S., et al. (2004) Mol. Cancer Ther. 3: 1543-1549.5. van Dongen, E.M., et al. (2004) Biochem. Biophys. Res. Commun. 323: 789-795.6. Samimi, G., et al. (2004) Mol Pharmacol 66: 25-32.7. Morgan, C.T., et al. (2004) J. Biol. Chem. 279: 36363-36371.8. Barnes, N., et al. (2005) J. Biol. Chem. [Epub].
Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
Conjugate: APC
Product Type: Monoclonal
Clone Number: L60/4 (Formerly sold as S60-4)
Immunogen: Synthetic peptide amino acids 42-61 (cytoplasmic C-terminus) of human Copper- transporting ATPase1
Swiss-Prot: Q04656
Purification: Protein G Purified
Storage Buffer: PBS pH7.4, 50% glycerol, 0.09% sodium azide *Storage buffer may change when conjugated
Concentration: 1 mg/ml
Specificity: Detects ~180kDa in rat brain membrane preparations.
Cellular Localization: Endoplasmic Reticulum,Cytoplasm,Golgi Apparatus,Trans-Golgi Network Membrane,Cell Membrane
Scientific Background: The copper efflux transporters ATP7A and ATP7B sequester intracellular copper into the vesicular secretory pathway for export from the cell. ATP7A (also known as Copper-transporting ATPase 1) functions as a transmembrane copper-trans locating P-type ATPase and plays a vital role in systemic copper absorption in the gut and copper reabsorption in the kidney. Polarized epithelial cells such as Madin-Darby canine kidney cells are a physiologically relevant model for systemic copper absorption and reabsorption in vivo. Although ATP7A is not detectable in most normal tissues, it is expressed in a considerable fraction of many common tumor types. Increased expression of ATP7A renders cells resistant to cisplatin and carboplatin. Mutations in the ATP7A gene result in Menkes disease, which is fatal in early childhood. Mutations in the ATP7B gene lead to the autosomal recessive disorder, Wilson disease, characterized by neurological symptoms and hepatic damage.
References: 1. Samimi G., et al. (2003) Clin. Cancer Res. 9: 5853-9.2. Samimi G., et al. (2004) Mol Pharmacol. 66: 25-32.3. Greenough M., et al. (2004) Am. J. Physiol. Cell Physiol. 287: C1463-71.4. Song, I.S., et al. (2004) Mol. Cancer Ther. 3: 1543-1549.5. van Dongen, E.M., et al. (2004) Biochem. Biophys. Res. Commun. 323: 789-795.6. Samimi, G., et al. (2004) Mol Pharmacol 66: 25-32.7. Morgan, C.T., et al. (2004) J. Biol. Chem. 279: 36363-36371.8. Barnes, N., et al. (2005) J. Biol. Chem. [Epub].
Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
| Artikelnummer | STRSMC-398D-APC |
|---|---|
| Hersteller | Stressmarq Biosciences |
| Hersteller Artikelnummer | SMC-398D-APC |
| Green Labware | Nein |
| Verpackungseinheit | 100 µg |
| Mengeneinheit | STK |
| Reaktivität | Human, Mouse (Murine), Rat (Rattus) |
| Klonalität | Monoclonal |
| Methode | Immunofluorescence, Immunoprecipitation, Western Blotting, Immunohistochemistry, Immunocytochemistry |
| Isotyp | IgG2b |
| Human Gene ID | 538 |
| Wirt | Mouse |
| Produktinformation (PDF) | Download |
| MSDS (PDF) | Download |
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
